Technology Offerings

New RSV Vaccine Uses Adenoviral Vectors for Prevention

Vaccine based on adenoviral vectors to prevent infection with the respiratory syncytial virus

Further Information: PDF

rubitec – Gesellschaft für Innovation und Technologie der Ruhr-Universität Bochum mbH
Phone: +49 (0)234/32-11969/11950

Contact
Dietmar Tappe

Comments (0)

Write a comment